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Paraoxonase 1 (PON1), a HDL-associated enzyme, is believed to contribute to the protective
effects of HDL by decreasing the generation of lipid peroxidation products during the process
of LDL oxidation. It has been reported that polymorphisms in promoter and coding regions of
the pon1 gene could affect PON1 activity. The aim of this study was to determine the frequen-
cies of pon1 polymorphisms Q192R, L55M and –108C>T and their influence on PON1 activity
in healthy population of Croatia. The following genotype frequencies were determined: 60 %
QQ, 34 % QR, 6 % RR for Q192R; 44 % LL, 43 % LM, 13 % MM for L55M; 30 % CC, 48 %
CT, 22 % TT for –108C>T polymorphism. Genotypes RR, LL and CC were found to be asso-
ciated with higher PON1 activity. The most frequent genotypes in healthy Croatian population
were QQ, CT and equally present LL and LM.
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INTRODUCTION
The paraoxonase gene family in humans includes three
genes (pon1, pon2 and pon3) located on the long arm of
chromosome 7. These genes share considerable similarity,
about 70 % homology at the nucleotide level and 60 %
at the amino acid level.1
Paraoxonase 1 (PON1) is a calcium-dependent este-
rase composed of 354 amino acids (45 kDa), which is
synthesized in the liver and secreted into the plasma where
it is associated with high-density lipoproteins (HDL). Low
PON1 levels has been found in chylomicrons and very
low-density lipoproteins (VLDL), but not in low-density
lipoproteins (LDL).2–4
PON1 hydrolyzes many active metabolites of organo-
phosphorus insecticides, including paraoxon (a catabolite
of the insecticide parathion), diazoxon and chlorpyrifos
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oxon, detoxifies various neurotoxic agents like sarin and
soman and hydrolyses the aliphatic lactones such as di-
hydrocoumarin, ã-butyrolactone and homocysteine thio-
lactone.5–7 PON1 is assumed to be involved in the lipid
metabolism and to be a protective factor against athero-
sclerosis. It prevents the formation of oxidized LDL, in-
activates LDL-derived oxidized phospholipids once they
are formed and prevents oxidation of HDL phospholipids.5
PON1 activity in human sera shows enormous interindi-
vidual variation ( 40 fold) as a result of genetic and en-
vironmental factors, including environmental chemicals,
pharmaceutical compounds, smoking, diet, alcohol, and
certain pathological and physiological conditions.8,9
Genetic factors include polymorphisms in the coding
and promoter regions of the pon1 gene that might influ-
ence the PON1 expression and its catalytic activity.10–13
Two common polymorphisms in the coding region of the
pon1 gene have been identified, Q192R glutamine to ar-
ginine substitution at position 192 and L55M leucine to
methionine substitution at position 55.14 Q192R polymor-
phism affects PON1 activity towards paraoxon, diazoxon,
soman and sarin and is associated with coronary artery
disease, stroke, familial hypercholesterolemia, type 2
diabetes and Parkinson’s disease. L55M polymorphism
can affect the PON1 mRNA and protein levels and its
activity. It might be implicated in stroke, coronary artery
disease, Parkinson’s disease, in variations of plasma to-
tal cholesterol and LDL cholesterol levels.15
Several polymorphisms have been reported in the
promoter region of the pon1 gene; thus, polymorphisms
at positions –108 (T or C), –126 (G or C), –162 (A or
G), –832 (G or A) and –909 (C or G).13,16,17 –108C>T
has been reported to be associated with PON1 expression
and activity, and with coronary artery disease.13,18–20
Considering the important role of pon1 gene poly-
morphisms in the genetic susceptibility to different disea-
ses and variability of distribution of these polymorphisms
in different ethnic groups, the aim of this study was to ex-
amine the distribution of pon1 Q192R, L55M and –108C>T
polymorphisms in healthy Croatian population, as well
as to determine the association of these polymorphisms
with PON1 activity toward paraoxon.
EXPERIMENTAL
Subjects
The study included 166 healthy unrelated individuals (85
male and 81 female subjects), aged 54 (42−67) years, living
in two different Croatian regions: Slavonski Brod (91 sub-
jects) and Split (75 subjects).
The study was approved by the Ethics Committees of
the »Dr. Josip Ben~evi}« General Hospital, Slavonski Brod
and University Hospital Split.
Samples
Blood samples were collected by venopuncture after over-
night fasting. Blood collected in EDTA-coated tubes was
used for determination of pon1 genotypes while sera were
analyzed for PON1 activity. Collected samples were stored
at −20 °C until analysis.
Genomic DNA was isolated from EDTA-anticoagulat-
ed blood by Miller’s method 21 and DNAwas stored at +4 °C
until further analysis.
Polymerase Chain Reaction (PCR)
Polymorphisms were determined by the polymerase chain
reaction followed by restriction fragment length polymor-
phism analysis (PCR-RFLP), as described by Campo et al.,
with a few modifications regarding sequence of forward pri-
mer, annealing temperature and endonuclease for –108C>T.22
Amplification was preformed for three DNA fragments
containing polymorphic sites Q192R (exon 6), L55M (exon
3) and –108C>T (promoter region). Amplification mixture
for each polymorphism (total volume 25 ìl) contained 250 ng
of genomic DNA, 0.4 ìmol dm–3 of each primer (Micro-
synth GmbH), 0.2 mmol dm–3 of each dNTP (Pharmacia Bio-
tech), 2 mmol dm–3 MgCl2 (Invitrogen), 0.5 units of Pla-
tinum Taq DNA Polymerase (1 unit of Platinum Taq DNA
Polymerase is the amount of enzyme required to incorpo-
rate 10 nmol of deoxyribonucleotide into acid-precipitable
material in 30 minutes at 74 °C; Invitrogen) and 2.5 ìl of
reaction buffer (200 mmol dm–3 Tris-HCl, pH = 8.4 and 500
mmol dm–3 KCl; Invitrogen).
The PCR reaction was performed in a GeneAmp PCR
System 9700 (Applied Biosystems) PCR machine. The fol-
lowing scheme was applied: the first step of predenatura-
tion at 95 °C for 12 minutes, 35 cycles of amplification (30
seconds at 94 °C followed by 30 seconds at specific primers
annealing temperature and 60 seconds at 72 °C for exten-
sion), and the last cycle of final extension at 72 °C for 7
minutes. PCR was attenuated by lowering the temperature
to 4 °C for at least 6 minutes.
Primers, annealing temperature and length of PCR pro-
ducts for each polymorphism explored in this study are gi-
ven in Table I.
Restriction Fragment Length Polymorphism (RFLP)
Each restriction endonuclease mixture (total volume 15 ìl)
contained 9 ìl of amplified fragment, an appropriate buffer
for each restriction endonuclease (Fermentas Life Sciences)
and 4 units of BspPI for Q192R, 5 units of Hin1II for L55M
and 3 units of BsrBI for −108C>T polymorphism (1 unit of
restriction enzyme is the amount of enzyme required to digest
1 µg of lambda DNA in 1 hour at 37 °C for Hin1II and BsrBI
or at 55 °C for BspPI).
Restriction products were separated by electrophoresis
on a 4 % agarose gel in TAE buffer (0.04 mol dm–3 Tris-HCl,
5 mmol dm–3 Na-acetate, 0.04 mmol dm–3 EDTA, pH = 7.9)
and stained with ethidium bromide (0.5 µg ml–1).
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Paraoxonase Activity
Paraoxonase activity was assayed by monitoring the release
of p-nitrophenol from paraoxon (O,O-diethyl-O-p-nitrophe-
nylphosphate, Sigma) in the presence of 1 mol dm–3 NaCl
(salt-stimulated activity).23,24 Serum (5 ìl) was added to
310 ìl of reaction mixture containing 2.0 mmol dm–3 para-
oxon, 2.0 mmol dm–3 CaCl2 in 0.1 mol dm
–3 Tris-HCl buf-
fer, pH = 8.0 and 1 mol dm–3 NaCl. The assay was carried
out using Olympus AU600 at 37 °C and the release of
p-nitrophenol was measured at 410/480 nm. Enzyme
activities are expressed in international units per 1 litre of
serum (1 international unit of enzyme activity is defined as
the catalytic amount of enzyme that catalyzes the reaction
rate of 1 µmol per minute in an assay system).
Statistical Analysis
SigmaStat for Windows version 3.00 (Copyright SPSS Inc.)
was used for statistical analysis. Comparisons of allele and
genotype frequencies were analyzed using the Chi-square
test. The Kolmogorov-Smirnov test of goodness of fit was
used to test the assumption of normal distribution for PON1
activity. The Kruskal-Wallis test was used for comparison
of PON1 activity and pon1 genotype. Comparisons of
PON1 activity with sex and ethnic determinations were
analyzed by the Mann-Whitney rank sum test. Quantitative
data were shown as median (interquartile range). P values
lower than 0.05 were considered statistically significant.
RESULTS AND DISCUSSION
Results of this study represent the PON1 activity and the
genotype and allele frequencies for Q192R, L55M and
–108C>T polymorphisms of the pon1 gene in healthy
Croatian population.
The samples were taken in two different regions of
Croatia, in the east around Slavonski Brod and in the south
around Split. Populations of these two regions have dif-
ferent lifestyle habits, particularly regarding food con-
sumption.
We did not detect any difference in PON1 activity
between male and female subjects (P = 0.887). In addi-
tion, there were no significant differences in distribution
of Q192R, L55M and –108C>T genotypes (P = 0.848 for
Q192R, P = 0.622 for L55M and P = 0.602 for –108C>T)
and PON1 activity (P = 0.071) among individuals living
in two different regions of Croatia, and we grouped all
the samples for determination of polymorphisms distri-
bution and PON1 activity. This data suggested that dif-
ferent diet and life habits might not have a significant
impact on PON1 activity in our study group.
Pon1 Polymorphisms
Exchange of codon CAA to CGA (exon 6) results in
substitution of amino acid glutamine with arginine at po-
sition 192 (Q192R) and introduces the restriction site for
BspPI endonuclease, while exchange of codon TTG to
ATG (exon 3) results in leucine to methionine substitu-
tion at position 55 (L55M) and introduces the restriction
site for Hin1II endonuclease (SNP ID for Q192R: rs662,
SNP ID for L55M: rs854560). The promoter region of
the pon1 gene has cytosine or thymine nucleotide base at
position –108 (SNP ID for –108C>T: rs705381). The pre-
sence of cytosine base at position –108 together with an
artificially introduced mismatch (marked as lower case
base a in the forward primer, see Table I) generated BsrBI
restriction site.
Restriction products were separated on 4 % agarose
gel and genotypes for each polymorphism were deter-
mined as described below.
Q192R polymorphism: undigested fragment (238 bp)
was detected in homozygotes for Q192 allele (genotype
QQ), digested fragments (175 and 63 bp) were detected
in homozygotes for R192 allele (genotype RR) and both
digested and undigested fragments (238, 175 and 63 bp)
were detected in heterozygotes (genotype QR, Figure 1).
L55M polymorphism: undigested fragment (172 bp)
was detected in homozygotes for L55 allele (LL geno-
type), digested fragments (103 and 69 bp) were detected
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TABLE I. PCR and RFLP conditions(a)
Poly-
morphism
Primer Tannealing
°C
Restriction
enzyme
PCR
fragment
RFLP
fragments
Q192R F: 5' TATTGTTGCTGTGGGACCTGAG 3' 60 BspPI 238 bp Q allele: 238 bp
R: 5' CCTGAGAATCTGAGTAAATCCACT 3' R allele: 175 + 63 bp
L55M F: 5' CCTGCAATAATATGAAACAACCTG 3' 63 Hin1II 172 bp L allele: 172 bp
R: 5' TGAAAGACTTAAACTGCCAGTC 3' M allele: 103 + 69 bp
–108C>T F: 5' AGCTAGCTGCCGACCCGGCGGGGAGGaG 3' 68 BsrBI 240 bp C allele: 212 + 28 bp
R: 5' GGCTGCAGCCCTCACCACAACCC 3' T allele: 240 bp
(a)The lower case of base ''a'' in pon1 –108C>T forward primer indicates a mismatch, introducing a restriction site for restriction enzyme BsrBI.
in homozygotes for M55 allele (genotype MM) and di-
gested and undigested fragments (172, 103 and 69 bp)
were detected in heterozygotes (genotype LM, Figure 2).
–108C>T polymorphism: undigested fragment (240
bp) was detected in homozygotes for T-108 allele (geno-
type TT), digested fragment (212 bp) was detected in
homozygotes for C-108 allele (genotype CC) and both
undigested and digested fragments (240 and 212 bp)
were detected in heterozygotes (genotype CT, Figure 3).
Genotype and allele frequency of pon1 coding (Q192R,
L55M) and promoter region –108C>T polymorphisms
are summarized in Table II. The most common genotype
in Croatian population was QQ (60 %) for Q192R and
CT (48 %) for –108C>T polymorphism, while polymor-
phism frequencies of both LL and LM genotypes were
almost equally represented for L55M (44 % and 43 %,
respectively). The most frequent alleles were Q (77 %)
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TABLE II. Genotype and allele frequency of pon1 polymorphisms in Croatian population(a)
Polymorphism Genotype Frequency Allele Frequency
N = 166 n % N = 332 n %
pon1 Q192R QQ 99 60 Q 254 77
QR 56 34 R 78 23
RR 11 6
pon1 L55M LL 74 44 L 219 66
LM 71 43 M 113 34
MM 21 13
pon1 –108C>T CC 50 30 C 180 54
CT 80 48 T 152 46
TT 36 22
(a)C/T denotes exchange of the nucleotide base at position –108 when the base immediately before the start codon is numbered ''–1''; Q/R and L/M
denote exchange of the amino acid at positions 192 and 55, respectively.
Figure 1. Determination of Q192R pon1 gene polymorphism by
the PCR-RFLP procedure using BspPI restriction enzyme. Lines 4, 6
QQ; lines 1, 2, 3 QR; and line 5 RR genotype.
Figure 2. Determination of L55M pon1 gene polymorphism by the
PCR-RFLP procedure using Hin1II restriction enzyme. Lines 4, 6 LL;
lines 1, 2, 3 LM; and line 5 MM genotype.
Figure 3. Determination of –108C>T pon1 gene polymorphism
by the PCR-RFLP procedure using BsrBI restriction enzyme. Line 6
CC; lines 2, 4, 5 CT; and lines 1, 3 TT genotype. Fragment of 28
bp is not visible on 4 % agarose gel.
for Q192R, L (66 %) for L55M and C (54 %) for
–108C>T polymorphisms of the pon1 gene. Observed
and expected genotype frequencies of all examined pon1
polymorphisms were in Hardy-Weinberg equilibrium.
Pon1 genotype and allele frequency were found to
vary between different ethnic groups (Table III). As
mentioned before, Croatian population has the highest
frequency of Q192 allele for Q192R and L55 allele for
L55M coding region polymorphisms.
These findings are in agreement with previously re-
ported data for European population, which showed pre-
dominance of Q192 and L55 alleles over R192 and M55
alleles.25–30 Asian population shows predominance of
R192 over Q192 allele and a very low frequency of M55
allele.16 When comparing European populations, as shown
in Table III, Croatian population has higher frequency of
Q192 allele for Q192R polymorphism than Turkish, Ita-
lian, Spanish, Dutch and Finnish populations. The observ-
ed variation in Q192 allele frequency is similar to pre-
viously reported data showing that European populations
have Q192 allele frequencies between 0.67 and 0.74.31
For the promoter region polymorphism in the group
examined in this study, the C-108 allele was predomi-
nant and its frequency was higher compared to Spanish
population. In contrast to allele frequency of two coding
region polymorphisms, the allele frequency of –108C>T
promoter polymorphism did not differ among various
ethnic groups.
Frequencies of combined haplotypes are shown in
Table IV. No individuals with the haplotype combina-
tions RR / MM, RR / LM, QR / MM or MM / CC were
identified in healthy Croatian population. The most fre-
quent haplotype combinations were QQ / LM (30 %),
QQ / CT (27 %) and LM / CT (27 %).
In our study, strong linkage disequilibrium was de-
tected between Q192R and L55M (P<0.001), and L55M
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TABLE III. llele frequencies of polymorphisms in different ethnic groups(a)
Ethnicity Q192R P L55M P –108C>T P Reference
Q R L M C T
Europe
Croatia 0.77 0.23 0.66 0.34 0.54 0.46
Turkey 0.69 0.31 0.015 0.72 0.28 0.077 ND ND 25
UK 0.78 0.22 0.924 0.70 0.30 0.517 0.52 0.48 0.809 26
Italy 0.65 0.35 0.016 0.66 0.34 0.918 0.57 0.43 0.722 27
Spain 0.70 0.30 0.040 0.63 0.37 0.332 0.46 0.54 0.015 28
Netherlands 0.68 0.32 0.010 0.63 0.37 0.399 ND ND 29
Finland 0.69 0.31 0.036 0.67 0.33 0.798 ND ND 30
Asia
Japan 0.40 0.60 <0.001 0.94 0.06 <0.001 0.48 0.52 0.161 16
(a)ND = not determined. P, levels of statistical significance after comparing presented populations with Croatian population using the Chi-square test.
TABLE IV. Combined haplotype distributions in Croatian population(a)
Q192R / L55M n (%) Q192R / –108C>T n (%) L55M / –108C>T n (%)
QQ / LL 29 (17) QQ / CC 29 (17) LL / CC 40 (24)
QQ / LM 49 (30) QQ / CT 44 (27) LL / CT 29 (18)
QQ / MM 21 (13) QQ / TT 26 (16) LL / TT 5 (3)
QR / LL 34 (20) QR / CC 17 (10) LM / CC 10 (6)
QR / LM 22 (13) QR / CT 30 (18) LM / CT 44 (27)
QR / MM 0 (0) QR / TT 9 (5) LM / TT 17 (10)
RR / LL 11 (7) RR / CC 4 (2) MM / CC 0 (0)
RR / LM 0 (0) RR / CT 6 (4) MM / CT 7 (4)
RR / MM 0 (0) RR / TT 1 (1) MM / TT 14 (8)
(a)Data are given as the number, n, and percentage (%) of individuals having a certain haplotype combination.
and –108C>T (P<0.001), while linkage disequilibrium
between Q192R and –108C>T was also significant, but
to a lesser extent (P = 0.045).
In Italian and Spanish population, however, linkage
disequilibrium has been observed between Q192R and
L55M, and L55M and –108C>T, but not between Q192R
and –108C>T polymorphisms.27,28
PON1 Activity
Paraoxonase activity (median activity 214 U L–1) show-
ed a wide interindividual variation ranging from 75 to
1272 U L–1.
Statistically significant variation of serum PON1 ac-
tivity was found to be related to Q192R, L55M and
–108C>T polymorphisms, as shown in Table V. Indivi-
duals with RR, LL or CC genotypes had the highest
PON1 activity, while the lowest PON1 activity was mea-
sured in individuals with QQ, MM or TT genotypes.
Combined effect of Q192R, L55M and –108C>T
polymorphisms on PON1 activity was also statistically
significant (P<0.001). The lowest PON1 activity was de-
tected in persons with QQ, MM and TT genotype com-
binations and the highest PON1 activity was detected in
persons with RR, LL and CC genotype combinations.
The effects of these polymorphisms on PON1 acti-
vity toward the substrate paraoxon were similar to some
previously reported results.28,32,33 It was shown that Q192R
polymorphism is responsible for the substrate-dependent
differences in the rate of hydrolysis.34,35 R192 alloenzy-
me hydrolyzes paraoxon faster than Q192 alloenzyme,
whereas other compounds, such as diazoxon, soman and
sarin, are hydrolyzed more rapidly by the Q192 alloen-
zyme.36 L55M polymorphism does not affect the cataly-
tic efficiency of substrate hydrolysis.34,35 However, the
M55 allele is associated with lower serum PON1 activity
and with lower PON1 protein and mRNA levels.11,12,37
Studies of pon1 promoter polymorphisms have shown that
–108C>T polymorphism affects PON1 expression. Asso-
ciation of the CC genotype with a high PON1 serum level
was stronger than in the case of the TT genotype.13,17
This work represents an epidemiological study of the
distribution of pon1 gene polymorphisms in healthy Croa-
tian population. The results confirmed the previously
suggested data that genetic factors (Q192R, L55M and
–108C>T pon1 gene polymorphisms) affect serum PON1
activity toward paraoxon. Frequencies of Q192R, L55M
and –108C>T polymorphisms correlated well with those
reported for European populations. Our results provide a
basis for examining the possible association of pon1 gene
polymorphisms with the development and/or progres-
sion of various diseases in Croatian population.
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Distribucija polimorfizama gena za paraoksonazu 1 u hrvatskoj populaciji
Marija Grdi}, Karmela Bari{i}, Lada Rumora, Ilza Salamuni}, Milena Tadijanovi},
Tihana @ani} Grubi{i}, Renata P{ikalová, Zlata Flegar-Me{tri} i Dubravka Jureti}
Paraoksonaza 1 (PON1) je enzim vezan na HDL koji smanjuje nakupljanje produkata lipidne peroksidacije
tijekom oksidacije LDL, pridonose}i na taj na~in za{titnoj ulozi HDL u procesu nastanka ateroskleroze. Poli-
morfizmi u promotorskoj i kodiraju}oj regiji pon1 gena utje~u na PON1 aktivnost. Cilj ovog istra`ivanja bio je
odrediti frekvencije polimorfizama Q192R, L55M i –108C>T i aktivnost PON1u zdravoj hrvatskoj populaciji.
Utvr|ene su sljede}e frekvencije genotipova: 60 % QQ, 34 % QR, i 6 % RR za Q192R; 44 % LL, 43 % LM i
13 % MM za L55M; 30 % CC, 48 % CT, 22 % TT za –108C>T polimorfizme pon1 gena. Genotipovi RR, LL i
CC povezani su s najvi{om PON1 aktivno{}u. Prema dobivenim rezultatima QQ, CT i podjednako zastupljeni
LL i LM genotipovi naju~estaliji su u zdravoj hrvatskoj populaciji.
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